Financial report interval: 2025.12.31 - 2026.03.31
Overview: Hicin Pharmaceutical(300584) the Revenue is 160.34 M (+12.4%);the EBIT is 20.17 M (-9.2%);the EPS is 0.145 (+15.48%).